Trial NCT02450331

View at ClinicalTrials.gov 
Org. Study IDs: WO29636
Secondary IDs: 2014-005603-25

Last trial update was posted on 2023-06-18

MeSH Interventions

Atezolizumab

MeSH Conditions

Carcinoma Carcinoma, Transitional Cell

Other Conditions


Stopping Reasons

Sponsor decided to terminate the study early because the study did not meet its primary endpoint and because the study had met its goals of providing safety and additional exploratory efficacy information for atezolizumab monotherapy in MIBC.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID